STAAR SURGICAL CO — Director's Dealing 2019

Jul 11, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2019-06-27

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	21323	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock Options	$8.64	2025-07-26	Common Stock Options (50000)		Direct
Common Stock Options	$7.52	2026-03-17	Common Stock Options (25000)		Direct
Common Stock Options	$9.30	2027-03-20	Common Stock Options (37500)		Direct
Common Stock Options	$16.15	2028-03-14	Common Stock Options (25000)		Direct
Common Stock Options	$29.80	2028-06-13	Common Stock Options (13484)		Direct
Common Stock Options	$35.98	2029-03-13	Common Stock Options (28026)		Direct

Footnotes

F1: Includes 6,250 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse on March 21, 2020.

F2: The options granted became exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (7/27/2015) and the remaining 2/3 vested in thirds on the following two anniversaries of the grant date, subject to continuous employment.

F3: The options granted became exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/18/2016) and the remaining 2/3 of such options became exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F4: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/21/2017) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F5: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/15/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F6: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (6/14/2018) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.

F7: The options granted become exercisable as follows: 1/3 upon completion of 12 months continuous employment from the date of grant (3/14/2019) and the remaining 2/3 of such options become exercisable over the following 24 months in equal amounts on a monthly basis, subject to continuous employment.